GENEVA, July 9 -- TARAN THERAPEUTICS, INC. filed a patent application (US2024/053765) for “COMBINATION TREATMENT OF CHRONIC MYELOMONOCYTIC LEUKEMIA IN PATIENTS WITH RAS PATHWAY MUTATIONS”. With publication no. WO/2025/096692, here are the other details related to the patent application:
Kind: Corrected version of pamphlet [A9]
IPC: A61K 39/395
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....